TORONTO — Somewhat reluctantly, Athar Afzal finally gave up on BlackBerry earlier this year. He was a longtime fan of the iconic Canadian phone brand but his company forced employees who weren’t already using iPhones to transition over. He was ready to make the change though, having grown fed up with the slowness of his […]
OTTAWA — If Kinder Morgan wants to abandon plans to build the Trans Mountain pipeline expansion, there are plenty of other investors out there willing to take up the cause — and they will have the backing of the federal Liberal government, Finance Minister Bill Morneau says. The government is willing to “provide indemnity” to […]
OTTAWA — Finance Minister Bill Morneau says if Kinder Morgan wants to abandon plans to build the Trans Mountain pipeline expansion, there are plenty of other investors out there willing to take up the cause. And Morneau says the federal Liberal government is willing to “provide indemnity” to those investors to ensure the controversial Alberta-B.C. […]
WASHINGTON — U.S. builders broke ground on fewer apartment buildings last month, pushing overall home construction down 3.7 per cent from March. The Commerce Department said Wednesday that housing starts fell to a seasonally adjusted annual rate of 1.29 million in April, lowest since December. Apartment construction tumbled 12.6 per cent to 374,000. Construction of […]
CINCINNATI (AP) — Macy’s Inc. (M) on Wednesday reported fiscal first-quarter earnings of $139 million. The Cincinnati-based company said it had profit of 45 cents per share. Earnings, adjusted for one-time gains and costs, were 48 cents per share. The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment […]
GENEVA — Novartis said Wednesday its top lawyer is retiring over the Swiss pharmaceutical company’s relationship with a firm owned by U.S. President Donald Trump’s personal lawyer, Michael Cohen. The Basel-based drugs company said general counsel Felix Ehrat is stepping down after about seven years in post “in the context of discussions surrounding Novartis’ former […]